Prabhavathi Fernandes, Ph.D., Founder, President and Chief Executive Officer

Dr. Prabhavathi Fernandes has been President and Chief Executive Officer of Cempra Pharmaceuticals since its inception in January 2006. She was previously President and Chief Executive Officer of DarPharma, Ricerca Biosciences and Small Molecule Therapeutics.

Prior to this, Dr. Fernandes held leadership positions at pharmaceutical corporations having worked at Bristol-Myers Squibb, Pharmaceutical Research Institute, Abbott Laboratories and The Squibb Institute for Medical Research. During these years she was directly involved in the development of antibiotics, four of which have been approved and one, Clarithromycin, achieving sales over a billion dollars. Dr. Fernandes has served on the U.S. Congressional Panel for Assessment of Impact of Antibiotic Resistant Bacteria and on the American Society for Microbiology Advisory Panel for Antibiotic Resistance. She serves on the editorial board of six journals, is a member of the Product Development working group for Biodefense for the NIAID, is an Advisory Board Member of Optimer Pharmaceuticals, Inc. and has written numerous publications and books. She was awarded a post-doctoral fellowship to Fox Chase Cancer Center from the National Institutes of Health and received her Ph.D. in Microbiology from Thomas Jefferson University.